This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of beta-blockers, which are widely used to manage cardiovascular conditions such as hypertension, angina, and arrhythmias. Its chiral structure is crucial for ensuring the desired stereochemistry in the final drug product, enhancing efficacy and reducing side effects. Additionally, it may be employed in the development of other therapeutic agents targeting adrenergic receptors, contributing to advancements in cardiovascular and neurological treatments.